United States FOR PHYSICIANS ABOUT US NEWSROOM CONTACT US Who We Are Leadership Team Board of Directors Investors Careers Who We Are Nevro Corp. was established with the vision of providing pain relief to those suffering from low back pain and other challenging types of chronic pain. Over 1.5 billion people suffer from chronic pain worldwide6, and back pain is the leading cause of disability for people under 45 years old.7 Inspired by work done at the Mayo Clinic, scientists at Nevro are developing a new high-frequency stimulation technology capable of delivering waveform of up to 10,000 Hz for spinal cord stimulation in the treatment of chronic pain. The Nevro® Senza® SCS system received CE Mark in 2010, TGA Approval in 2011 and is commercially available in Europe and Australia. In the United States, the Senza SCS system is for investigational use only. A pivotal clinical trial is currently in progress, which is intended to collect data to support an application for U.S. approval of a Nevro Senza implantable spinal cord stimulation system. 6 Global Industry Analysts, Inc. Report, January 10, 2011. 7 National Centers for Health Statistics, Chartbook on Trends in the Health of Americans 2006, Special Feature: Pain HIGH-FREQUENCY SCS Nevro is developing a new high-frequency stimulation technology for chronic pain. Learn More » CONTACT US Questions? Please contact us for more information. Home | For Physicians | About Us | Newsroom | Contact Us © 2014 Nevro Corp. All rights reserved. Legal Notice | Patents | Privacy The Senza® SCS system is an investigational device in the United States. It is limited by U.S. law to investigational use only. Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro Corp.